Clinical trial
Thymus Transplantation Safety-Efficacy
NCT01220531 · Sumitomo Pharma Switzerland GmbH, Industry · Completed
Key facts
| NCT number | NCT01220531 |
|---|---|
| Title | Thymus Transplantation Safety-Efficacy |
| Official title | Safety and Efficacy of Thymus Transplantation in Complete DiGeorge Anomaly, IND#9836 |
| Lead sponsor | Sumitomo Pharma Switzerland GmbH, Industry |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Study type | Interventional |
| Conditions | Complete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge Syndrome |
| Intervention type | Biological |
| Interventions | Cultured Thymus Tissue |
| Enrollment | 29 |
| Start date | Dec 1, 2010 |
| Primary completion | Aug 1, 2023 |
| Completion | Aug 1, 2023 |
| First posted | Oct 14, 2010 |
| Last update posted | Jan 16, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: